The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: How Informatics Can Assist the Secondary Use of Electronic Health Records to Inform Regulatory Decisions.

Azadeh Shoaibi, Hui-Lee Wong, Christian Reich, Keran Moll, Tina Hernandez-Boussard

Browse the full AMIA paper archive.